{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:27:43Z","timestamp":1790782063555,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ando.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T12:30:19Z","timestamp":1714566619000},"page":"269-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ovarian reserve in patients with FMR1 gene premutation and the role of fertility preservation"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2795-831X","authenticated-orcid":false,"given":"Tiphaine","family":"Le Poulennec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grynberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Sermondade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Fourati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Siffroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"H\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bachelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ando.2024.04.004_bib0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00293026","article-title":"Analysis of the fragile-X chromosome: localization and detection of the fragile site in high resolution preparations","volume":"69","author":"Krawczun","year":"1985","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.ando.2024.04.004_bib0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cge.13075","article-title":"Fragile X syndrome: an overview and update of the FMR1 gene","volume":"93","author":"Mila","year":"2018","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.ando.2024.04.004_bib0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1620\/tjem.239.57","article-title":"Pathological effects of the FMR1 CGG-repeat polymorphism (5\u201355 repeat numbers): systematic review and meta-analysis","volume":"239","author":"Yang","year":"2016","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"10.1016\/j.ando.2024.04.004_bib0260","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00125817-200105000-00010","volume":"3","author":"Maddalena","year":"2001","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.ando.2024.04.004_bib0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/genes15010006","article-title":"PGT-M for premature ovarian failure related to CGG repeat expansion of the FMR1 gene","volume":"15","author":"Persico","year":"2023","journal-title":"Genes"},{"issue":"4","key":"10.1016\/j.ando.2024.04.004_bib0270","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/ijms23041935","article-title":"Fragile X syndrome: from molecular aspect to clinical treatment","volume":"23","author":"Protic","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.ando.2024.04.004_bib0275","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/gm401","article-title":"FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States","volume":"4","author":"Tassone","year":"2012","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.ando.2024.04.004_bib0280","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0031-1280915","article-title":"FMR1 and the continuum of primary ovarian insufficiency","volume":"29","author":"Sullivan","year":"2011","journal-title":"Semin Reprod Med"},{"issue":"4","key":"10.1016\/j.ando.2024.04.004_bib0285","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.2007.03073.x","article-title":"Primary ovarian insufficiency: a more accurate term for premature ovarian failure","volume":"68","author":"Welt","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ando.2024.04.004_bib0290","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B","article-title":"Fragile X premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in fragile X study--preliminary data","volume":"83","author":"Allingham-Hawkins","year":"1999","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.ando.2024.04.004_bib0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ando.2021.09.001","article-title":"Position statement on the diagnosis and management of premature\/primary ovarian insufficiency (except Turner Syndrome)","volume":"82","author":"Christin-Maitre","year":"2021","journal-title":"Ann Endocrinol"},{"issue":"3","key":"10.1016\/j.ando.2024.04.004_bib0300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J","article-title":"Premature ovarian failure in the fragile X syndrome","volume":"97","author":"Sherman","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ando.2024.04.004_bib0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1196\/annals.1429.029","article-title":"Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile X-associated primary ovarian insufficiency","volume":"1135","author":"De Caro","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.ando.2024.04.004_bib0310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10815-022-02671-1","article-title":"The diagnostic experience of women with fragile X-associated primary ovarian insufficiency (FXPOI)","volume":"40","author":"Poteet","year":"2023","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"10.1016\/j.ando.2024.04.004_bib0315","first-page":"1252","article-title":"Familial transmission of the FMR1 CGG repeat","volume":"59","author":"Nolin","year":"1996","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.ando.2024.04.004_bib0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/1096-8628(200022)97:2<153::AID-AJMG7>3.0.CO;2-M","article-title":"FMR1 gene and fragile X syndrome","volume":"97","author":"Bardoni","year":"2000","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1016\/j.ando.2024.04.004_bib0325","first-page":"199","article-title":"[Fragile X associated tremor\/ataxia syndrome: its clinical presentation, pathology, and treatment]","volume":"68","author":"Salcedo-Arellano","year":"2019","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.ando.2024.04.004_bib0330","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s11689-018-9261-x","article-title":"Static and dynamic postural control deficits in aging fragile X mental retardation 1 (FMR1) gene premutation carriers","volume":"11","author":"Wang","year":"2019","journal-title":"J Neurodev Disord"},{"issue":"5","key":"10.1016\/j.ando.2024.04.004_bib0335","doi-asserted-by":"crossref","first-page":"e12565","DOI":"10.1111\/gbb.12565","article-title":"Fragile X-associated tremor\/ataxia syndrome: regional decrease of mitochondrial DNA copy number relates to clinical manifestations","volume":"18","author":"Alvarez-Mora","year":"2019","journal-title":"Genes Brain Behav"},{"issue":"18","key":"10.1016\/j.ando.2024.04.004_bib0340","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.3390\/cells12182330","article-title":"Insight and recommendations for fragile X-premutation-associated conditions from the fifth international conference on FMR1 premutation","volume":"12","author":"Tassone","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ando.2024.04.004_bib0345","doi-asserted-by":"crossref","first-page":"e22612","DOI":"10.1096\/fj.202200468RR","article-title":"Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency","volume":"36","author":"Rosario","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.ando.2024.04.004_bib0350","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnmol.2017.00290","article-title":"Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations","volume":"10","author":"Man","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"10.1016\/j.ando.2024.04.004_bib0355","first-page":"117","article-title":"Reproduction in premature ovarian insufficiency patients \u2013 from latest studies to therapeutic approach","volume":"17","author":"M\u0119czekalski","year":"2018","journal-title":"Prz Menopauzalny"},{"issue":"11","key":"10.1016\/j.ando.2024.04.004_bib0360","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1210\/clinem\/dgac536","article-title":"Granulosa cell dysfunction is associated with diminished ovarian response in FMR1 premutation carriers","volume":"107","author":"Boustanai","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ando.2024.04.004_bib0365","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/humrep\/dex090","article-title":"The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal","volume":"32","author":"Avraham","year":"2017","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ando.2024.04.004_bib0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ejhg.2015.96","article-title":"Improving preimplantation genetic diagnosis for fragile X syndrome: two new powerful single-round multiplex indirect and direct tests","volume":"24","author":"Kieffer","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.ando.2024.04.004_bib0375","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.mayocp.2019.10.009","article-title":"Fertility preservation in women: indications and options for therapy","volume":"95","author":"Hussein","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.ando.2024.04.004_bib0380","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.fertnstert.2016.02.011","article-title":"Is FMR1 CGG repeat length a predictor of in vitro fertilization stimulation response or outcome?","volume":"105","author":"Banks","year":"2016","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ando.2024.04.004_bib0385","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.rbmo.2016.02.009","article-title":"FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles","volume":"32","author":"Morin","year":"2016","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.ando.2024.04.004_bib0390","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.rbmo.2018.11.009","article-title":"Does the FMR1 gene affect IVF success?","volume":"38","author":"Pastore","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10.1016\/j.ando.2024.04.004_bib0395","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE guideline: management of women with premature ovarian insufficiency","volume":"31","author":"Webber","year":"2016","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.ando.2024.04.004_bib0400","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/humrep\/dem148","article-title":"Examination of reproductive aging milestones among women who carry the FMR1 premutation","volume":"22","author":"Allen","year":"2007","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.ando.2024.04.004_bib0405","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10815-015-0595-y","article-title":"Diminished ovarian reserve, premature ovarian failure, poor ovarian responder--a plea for universal definitions","volume":"32","author":"Cohen","year":"2015","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"10.1016\/j.ando.2024.04.004_bib0410","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/humrep\/14.5.1217","article-title":"Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women","volume":"14","author":"Murray","year":"1999","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ando.2024.04.004_bib0415","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/humrep\/den050","article-title":"Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study","volume":"23","author":"Rohr","year":"2008","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.ando.2024.04.004_bib0420","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/humrep\/der146","article-title":"Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers","volume":"26","author":"Spath","year":"2011","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.ando.2024.04.004_bib0425","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/gim.2017.220","article-title":"CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve","volume":"20","author":"Lekovich","year":"2018","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.ando.2024.04.004_bib0430","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12958-022-00919-0","article-title":"Activation of AKT\/mammalian target of rapamycin signaling in the peripheral blood of women with premature ovarian insufficiency and its correlation with FMR1 expression","volume":"20","author":"Rehnitz","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"10.1016\/j.ando.2024.04.004_bib0435","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ejhg.5201510","article-title":"Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers","volume":"14","author":"Ennis","year":"2006","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.ando.2024.04.004_bib0440","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","article-title":"The FMR1 premutation and reproduction","volume":"87","author":"Wittenberger","year":"2007","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.ando.2024.04.004_bib0445","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/GME.0000000000000658","article-title":"Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI)","volume":"23","author":"Hipp","year":"2016","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.ando.2024.04.004_bib0450","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.rbmo.2015.11.009","article-title":"Reproductive characteristics of women diagnosed with premature ovarian insufficiency","volume":"32","author":"Daan","year":"2016","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10.1016\/j.ando.2024.04.004_bib0455","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/5.5.483","article-title":"Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy","volume":"5","author":"van Kasteren","year":"1999","journal-title":"Hum Reprod Update"},{"issue":"12","key":"10.1016\/j.ando.2024.04.004_bib0460","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/jc.2011-1038","article-title":"Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure","volume":"96","author":"Bidet","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ando.2024.04.004_bib0465","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/humrep\/deab214","article-title":"What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome?","volume":"36","author":"Sonigo","year":"2021","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.ando.2024.04.004_bib0470","doi-asserted-by":"crossref","first-page":"735","DOI":"10.5603\/GP.a2021.0180","article-title":"Can FMR1 CGG repeat lengths predict the outcome in ICSI cycles?","volume":"93","author":"Cogendez","year":"2022","journal-title":"Ginekol Pol"},{"issue":"3","key":"10.1016\/j.ando.2024.04.004_bib0475","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.fertnstert.2009.04.047","article-title":"The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis","volume":"94","author":"Bibi","year":"2010","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ando.2024.04.004_bib0480","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1701-2163(16)35087-3","article-title":"Advanced reproductive age and fertility","volume":"33","author":"Liu","year":"2011","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:42:07Z","timestamp":1728470527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426624000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0003426624000520"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2024.04.004","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian reserve in patients with FMR1 gene premutation and the role of fertility preservation","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}